BioXcel Therapeutics (BTAIQ) Receivables (2022 - 2026)
BioXcel Therapeutics (BTAIQ) posted Receivables of $82,000 for Q2 2026, up 382.4% from $17,000 a year earlier but down 62.0% from the prior quarter.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) Receivables (2022 - 2026) Analysis & Trends
At the end of FY2025, BioXcel Therapeutics' Receivables came in at $233,000, up 77.9% from FY2024.
- Annual Receivables shows a three-year compound annual growth rate of -2.1% (FY2022 to FY2025).
- In prior years, BioXcel Therapeutics' Receivables was $131,000 in FY2024 (+84.5%), $71,000 in FY2023 (-71.4%) and $248,000 in FY2022.
- Quarterly Receivables has run from a low of $3,000 in Q3 2024 to a high of $812,000 in Q2 2024 over five years.
- On a year-over-year basis, Receivables increased in three of the last five quarters, with growth averaging 69.4%.
- The strongest year-over-year quarter for Receivables in the past five years was Q2 2026, with growth of 382.4%; the weakest was Q3 2024, with a decline of 99.6%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 2.13 Bn |
| 10 | BioXcel Therapeutics | 1.57 Mn | 1.57 Mn | 160,000.00 | 82,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 82,000.00 |
| Mar 31, 2026 | 216,000.00 |
| Dec 31, 2025 | 233,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2023 | 71,000.00 |
| Sep 30, 2023 | 735,000.00 |
| Jun 30, 2023 | 431,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 248,000.00 |
API Access
BioXcel Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();